RESUMEN
The use of the medicinal leech (Hirudo medicinalis) in promoting venous drainage in tissues whose vitality is threatened by venous congestion and obstruction, especially in plastic and reconstructive surgery, has been complicated by infections caused by Aeromonas spp. These are leech endosymbionts for which patients undergoing hirudotherapy frequently receive systemic chemoprophylaxis. In order to evaluate the possibility of rendering leeches safe for use on patients, H. medicinalis were fed artificially with a 2 g/L arginine solution (used as a phagostimulant) supplemented with ciprofloxacin (100 mg/L). Aeromonads were detected in 57 out of 80 control leeches (71.3%), but in none of the 56 leeches treated with ciprofloxacin (p <0.001). Treated leeches survived for up to 4 months. Tested weekly, 61% of these leeches took human blood for at least 4 weeks after treatment and all remained negative for aeromonads. All water samples in which leeches were kept before treatment were contaminated with Aeromonas spp.; none were detected in any of the NaCl/arginine solutions with which treated animals were fed. Molecular characterization of two phenotypically distinct isolates using gyrB sequencing showed that one clustered tightly with A. veronii and the other was closely related to A. media. Other environmental bacteria and fungi were isolated from 26.5% of treated leeches that had taken a blood meal 1-4 weeks after treatment. Ciprofloxacin reduced the number of leech-associated aeromonads to undetectable levels for extended periods. Most treated leeches were ready to take a blood meal after treatment, suggesting the possibility of using ciprofloxacin-treated leeches instead of chemoprophylaxis in patients undergoing hirudotherapy.
Asunto(s)
Aeromonas/efectos de los fármacos , Aeromonas/aislamiento & purificación , Antibacterianos/administración & dosificación , Ciprofloxacina/administración & dosificación , Hirudo medicinalis/microbiología , Aeromonas/clasificación , Aeromonas/genética , Animales , Proteínas Bacterianas/genética , Análisis por Conglomerados , Girasa de ADN/genética , Hongos/clasificación , Hongos/aislamiento & purificación , Tracto Gastrointestinal/microbiología , Genotipo , Humanos , Aplicación de Sanguijuelas/métodos , Análisis de Secuencia de ADN , Homología de SecuenciaRESUMEN
Low molecular weight compounds were isolated by high-performance liquid chromatography from the maggot or haemolymph extracts of Lucilia sericata (Meigen) (Diptera: Calliphoridae). Using gas chromatography-mass spectrometry analysis, three compounds were obtained: p-hydroxybenzoic acid (molecular weight 138 Da), p-hydroxyphenylacetic acid (molecular weight 152 Da) and octahydro-dipyrrolo[1,2-a;1',2'-d] pyrazine-5,10-dione (molecular weight 194 Da), also known as the cyclic dimer of proline (or proline diketopiperazine or cyclo[Pro,Pro]). All three molecules revealed antibacterial activity when tested against Micrococcus luteus and/or Pseudomonas aeruginosa, and the effect was even more pronounced when these molecules were tested in combination and caused lysis of these bacteria.
Asunto(s)
Antibacterianos/aislamiento & purificación , Dípteros/química , Hidroxibenzoatos/aislamiento & purificación , Péptidos Cíclicos/aislamiento & purificación , Fenilacetatos/aislamiento & purificación , Animales , Antibacterianos/química , Antibacterianos/farmacología , Cromatografía Líquida de Alta Presión/veterinaria , Hemolinfa/química , Hidroxibenzoatos/química , Hidroxibenzoatos/farmacología , Larva/química , Pruebas de Sensibilidad Microbiana , Micrococcus luteus/efectos de los fármacos , Peso Molecular , Péptidos Cíclicos/química , Péptidos Cíclicos/farmacología , Fenilacetatos/química , Fenilacetatos/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Células Madre , Factores de TiempoRESUMEN
OBJECTIVE: To partially characterise maggot-secreted antibacterial substances and determine their range of activity against different bacteria. METHOD: Sterile and non-sterile maggots maintained in the laboratory and taken from chronic wounds of treated patients were used. Whole body extracts and haemolymph were fractionated and their range of activity against bacteria was tested using the zone of inhibition assay. The mode of action of bacterial destruction was examined by viable counts, influx of K+ and changes in the membrane potential by scanning electron microscope (SEM). RESULTS: Extracts of sterile and non-sterile maggots showed an activity of 200 arbitrary units (AU)/ml and 400AU/ml respectively. Maggots removed from chronic wounds had an activity of 1200AU/ml. Injuring sterile maggots with a sterile needle doubled the antibacterial activity within 24 hours, while the antibacterial activity of haemolymph increased fourfold after injury with a sterile needle and sixteenfold with an infected needle. The fractions with a molecular weight of < 1kDa and 3-10kDa showed antibacterial activity against Gram-positive and Gram-negative bacteria including Pseudomonas aeruginosa, Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from wounds. The fraction with a molecular weight of < 1kDa lysed over 90% of the bacteria within 15 minutes by causing an influx of K+ and changing the membrane potential of bacteria. CONCLUSION: The nature of the antibacterial materials extracted from maggots not only indicates their ability to ingest the necrotic tissue on the wound, but also their potential significance in wound healing,